Evidence map›Paper›PMID 34819991›Full record

ArticleComputational and mathematical methods in medicine2021

The Value of CTA Based on Gold Nanorod Contrast Agent in Coronary Artery Diagnosis and Plaque Property Analysis.

Heyu Bi, Liangshi Wang, Shupeng Wang, Qicheng Huang, Yue Sun

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Heyu BiDepartment of Internal Medicine, Qiqihar Jianhua District Community Hospital, China.
Liangshi WangCenter for Medical Imaging, The Third Hospital Affiliated Qiqihar Medical University, Qiqihar, 161000 Heilongjiang, China.
Shupeng WangCenter for Medical Imaging, The Third Hospital Affiliated Qiqihar Medical University, Qiqihar, 161000 Heilongjiang, China.
Qicheng HuangCenter for Medical Imaging, The Third Hospital Affiliated Qiqihar Medical University, Qiqihar, 161000 Heilongjiang, China.
Yue SunCenter for Medical Imaging, The Third Hospital Affiliated Qiqihar Medical University, Qiqihar, 161000 Heilongjiang, China.ORCID https://orcid.org/0000-0002-0749-3253
Qiqihar Medical University · CNCommunity Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary CT angiography (CTA) with the characteristics of noninvasive and simple operation is widely used in the diagnosis of coronary artery stenosis. The choice of contrast agent exerts an important impact on the imaging quality of CTA. Conventional iodine contrast agents are easily excreted by the kidneys, from which the imaging window is short, and the imaging quality is poor. Metal nanomaterials have unique optical properties and have broad application prospects in imaging. Our aim is to explore the value of gold nanorod contrast agent in the diagnosis of coronary heart disease. A gold nanorod suspension was first prepared, and the prepared gold nanorod was uniform and had good dispersibility. It can be seen from the light absorption curve that there are two obvious peaks on the UV absorption peak of the gold nanorods. The gold nanorods were cultured in different solutions, and it was found that the particle size of the gold nanorods did not change significantly within 72 hours, indicating that the prepared gold nanorods had good stability. When observing the damage degree of mouse kidney tissue, it was shown that the damage degree of gold nanorod contrast agent to mouse kidney tissue was less than that of iodine contrast agent. The above results indicate that the gold nanorod contrast agent has good stability and safety. Therefore, our study demonstrated that the gold nanorod contrast agent has high value in the diagnosis of coronary arteries and the analysis of plaque properties.

Indexed as

Contrast MediaGoldMetal NanoparticlesNanotubesAnimalsComputational BiologyComputed Tomography AngiographyCoronary Artery DiseaseDrug StabilityHumansIodineKidneyMaleMiceMice, Knockout, ApoEParticle SizeContrast MediaGoldIodine

Identifiers

PMID34819991
PMCPMC8608500
OpenAlexW3214644869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.